- Home
- WEST vs LXRX Comparison
WEST vs LXRX Comparison
Compare WEST & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- LXRX
- Stock Information
- Founded
- WEST 2009
- LXRX 1995
- Country
- WEST United States
- LXRX United States
- Employees
- WEST N/A
- LXRX N/A
- Industry
- WEST Beverages (Production/Distribution)
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- WEST Consumer Staples
- LXRX Health Care
- Exchange
- WEST Nasdaq
- LXRX Nasdaq
- Market Cap
- WEST 512.4M
- LXRX 428.8M
- IPO Year
- WEST N/A
- LXRX 2000
- Fundamental
- Price
- WEST $5.26
- LXRX $1.10
- Analyst Decision
- WEST Strong Buy
- LXRX Buy
- Analyst Count
- WEST 5
- LXRX 5
- Target Price
- WEST $10.60
- LXRX $3.23
- AVG Volume (30 Days)
- WEST 609.1K
- LXRX 1.6M
- Earning Date
- WEST 11-06-2025
- LXRX 11-11-2025
- Dividend Yield
- WEST N/A
- LXRX N/A
- EPS Growth
- WEST N/A
- LXRX N/A
- EPS
- WEST N/A
- LXRX N/A
- Revenue
- WEST $944,492,000.00
- LXRX $58,432,000.00
- Revenue This Year
- WEST $28.24
- LXRX N/A
- Revenue Next Year
- WEST $9.81
- LXRX N/A
- P/E Ratio
- WEST N/A
- LXRX N/A
- Revenue Growth
- WEST 13.05
- LXRX 1504.83
- 52 Week Low
- WEST $5.04
- LXRX $0.28
- 52 Week High
- WEST $8.29
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- WEST 39.20
- LXRX 48.85
- Support Level
- WEST $5.11
- LXRX $1.03
- Resistance Level
- WEST $5.58
- LXRX $1.19
- Average True Range (ATR)
- WEST 0.30
- LXRX 0.06
- MACD
- WEST 0.00
- LXRX -0.00
- Stochastic Oscillator
- WEST 22.92
- LXRX 41.18
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.